Utility of 18F-FDG PET-CT metrics predicting lymph node involvement in locally advanced breast cancer

被引：0
|
作者：
Pitalua Cortes, Q. [1 ]
Garcia Perez, O. [1 ]
Torres Agredo, L. [2 ]
Esparza Arias, N. [1 ]
机构：
[1] Inst Nacl Cancerol, Mexico City, DF, Mexico
[2] Univ Autonoma Bucaramanga, Bucaramanga, Colombia
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2021年 / 48卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-008
引用
收藏
页码：S519 / S519
页数：1
相关论文
共 50 条
  • [1] 18F-FDG PET-CT utility in initial axillary staging in locally advanced breast cancer candidates to neoadjuvant chemotherapy
    Serrano Palacio, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S473 - S473
  • [2] 18F-FDG PET-CT Predicting Pathological Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer
    Sanchez Fuentes, D.
    Pedraza Fernandez, S.
    Ruiz Solis, S.
    Hernandez Martinez, A.
    Sarandeses Fernandez, P.
    Gomez Grande, A.
    Perez-Escutia, M.
    Estenoz Alfaro, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S666 - S667
  • [3] 18F-FDG PET-CT as a Tool for Predicting the Immunohistochemical Profile of Breast Cancer
    Wakankar, R.
    Bal, J.
    Dougall, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S478 - S479
  • [4] Mediastinal schwannoma mimicking lymph node metastasis from locally advanced breast cancer in a 18F-FDG PET/CT study
    Martinez-Esteve, A.
    Alvarez-Perez, R. M.
    Pachon-Garrudo, V. M.
    Gonzalez-Mancha, R.
    Borrego-Dorado, I.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2016, 35 (04): : 272 - 273
  • [5] 18F-FDG PET/CT Radiomics Of Cervical Cancer In Predicting Lymph Node Metastasis
    Monaco, L.
    Mathoux, G.
    Crivellaro, C.
    Elisei, F.
    Buda, A.
    Fruscio, R.
    Landoni, C.
    Guerra, L.
    Messa, C.
    De Bernardi, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S233 - S234
  • [6] Locoregional lymph node involvement on 18F-FDG PET/CT in breast cancer patients scheduled for neoadjuvant chemotherapy
    Koolen, Bas B.
    Olmos, Renato A. Valdes
    Elkhuizen, Paula H. M.
    Vogel, Wouter V.
    Peeters, Marie-Jeanne T. F. D. Vrancken
    Rodenhuis, Sjoerd
    Rutgers, Emiel J. Th.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 135 (01) : 231 - 240
  • [7] Locoregional lymph node involvement on 18F-FDG PET/CT in breast cancer patients scheduled for neoadjuvant chemotherapy
    Bas B. Koolen
    Renato A. Valdés Olmos
    Paula H. M. Elkhuizen
    Wouter V. Vogel
    Marie-Jeanne T. F. D. Vrancken Peeters
    Sjoerd Rodenhuis
    Emiel J. Th. Rutgers
    Breast Cancer Research and Treatment, 2012, 135 : 231 - 240
  • [8] Early and delayed prediction of axillary lymph node neoadjuvant response by 18F-FDG PET/CT in patients with locally advanced breast cancer
    Garcia Vicente, Ana Maria
    Soriano Castrejon, Angel
    Leon Martin, Alberto
    Relea Calatayud, Fernanda
    Munoz Sanchez, Maria del Mar
    Cruz Mora, Miguel Angel
    Jimenez Londono, German Andres
    Espinosa Aunion, Ruth
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (07) : 1309 - 1318
  • [9] Early and delayed prediction of axillary lymph node neoadjuvant response by 18F-FDG PET/CT in patients with locally advanced breast cancer
    Ana María García Vicente
    Ángel Soriano Castrejón
    Alberto León Martín
    Fernanda Relea Calatayud
    María del Mar Muñoz Sánchez
    Miguel Ángel Cruz Mora
    Germán Andrés Jiménez Londoño
    Ruth Espinosa Aunión
    European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41 : 1309 - 1318
  • [10] The Role of 18F-FDG PET/CT in Predicting the Neoadjuvant Treatment Response in Patients with Locally Advanced Breast Cancer
    Goktas Aydin, Sabin
    Bilici, Ahmet
    Olmez, Omer Fatih
    Oven, Basak B. B.
    Acikgoz, Ozgur
    Cakir, Tansel
    Basim, Pelin
    Cakir, Asli
    Kutlu, Yasin
    Hamdard, Jamshid
    BREAST CARE, 2022, 17 (05) : 470 - 479
12345